secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0001193125-25-001911
Event type: other_material
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 2.02, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical secures $168.8M equity private placement and $125M debt facility, reports $113M 2024 revenue
--------------------------------------------------------------------------------

- Private placement of 843,908 Series A convertible preferred shares at $200/share for ~$168.8M gross proceeds; insiders to invest additional $3.9M subject to shareholder approval.
- New $125M senior secured credit facility from Perceptive Advisors: $100M initial term loan plus up to $25M delayed draw, maturity 2030, SOFR+8% with 2-year PIK component.
- Proceeds used to repay in full ~$200M of existing credit facilities (maturing 2027) with SLR Investment and Gemino; expected to have ~$210M cash and $100M debt post-closing.
- Preliminary unaudited Q4 2024 revenue of $29M and FY 2024 revenue of $113M, ahead of prior guidance.
- Financing led by PFM Health Sciences and Perceptive Advisors; expected to close Jan 8, 2025, and fund operations through cashflow breakeven.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000119312525001911/0001193125-25-001911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000119312525001911/d900977d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-001911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer